目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 RESEARCH SCOPE
1.3.1 MARKET COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 MAJOR MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA SOURCES
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
2.1.2.1 PRIMARY SOURCES
2.1.2.2 KEY INDUSTRY INSIGHTS
2.1.2.3 BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.2.1 REVENUE-MAPPING BASED MARKET ESTIMATION
2.2.2 PROCEDURE BASED MARKET ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RECESSION IMPACT ASSESMENT APPROACH
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 SCOPE RELATED LIMITATIONS
2.6.2 METHODOLOGY RELATED LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
5.1.1 DRIVERS
5.1.2 RESTRAINTS
5.1.3 KEY GROWTH OPPORTUNITIES
5.1.4 INDUSTRY-SPECIFIC CHALLENGES
5.2 PORTER’S FIVE FORCES ANALYSIS
5.3 REGULATORY LANDSCAPE
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANISATIONS
5.3.2 REGULATORY TRENDS
5.4 REIMBURSEMENT SCENARIO
5.5 ECOSYSTEM COVERAGE
5.6 VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY
5.8.2 AVERAGE SELLING PRICE TREND, BY REGION
5.9 PATENT ANALYSIS
5.10 TRADE ANALYSIS
5.11 TECHNOLOGY ANALYSIS
5.12 KEY CONFERENCES & EVENTS IN 2023-2024
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS
5.14.2 BUYING CRITERIA
5.15 CASE STUDY ANALYSIS

6 MEDICAL AESTHETICS MARKET, BY PRODUCT (USD MILLION; 2021—2028)
6.1 FACIAL AESTHETIC PRODUCTS
6.1.1 BOTULINUM TOXIN
6.1.2 DERMAL FILLERS
6.1.3 MICRODERMABRASION PRODUCTS
6.1.4 CHEMICALS PEELS
6.2 COSMETICS IMPLANTS
6.2.1 BREAST IMPLANTS
6.2.1.1 SILICONE BREAST IMPLANTS
6.2.1.2 SALINE BREAST IMPLANTS
6.2.2 GLUTEAL IMPLANTS
6.2.3 FACIAL IMPLANTS
6.3 SKIN AESTHETIC DEVICES
6.3.1 NONSURGICAL SKIN TIGHTENING DEVICES
6.3.2 LASER SKIN RESURFACING DEVICES
6.3.3 MICRO NEEDLING PRODUCTS
6.3.4 LIGHT THERAPY DEVICES
6.4 BODY CONTOURING DEVICES
6.4.1 NONSURGICAL FAT REDUCTION DEVICES
6.4.2 CELLULITE REDUCTION DEVICES
6.4.3 LIPOSUCTIONS DEVICES
6.5 PHYSICIAN-DISPENSED COSMECEUTICALS AND SKIN LIGHTENERS
6.6 HAIR REMOVAL DEVICES
6.6.1 LASER HAIR REMOVAL DEVICES
6.6.2 IPL HAIR REMOVAL DEVICES
6.7 TATTOO REMOVAL DEVICES
6.8 THREAD LIFT PRODUCTS
6.9 PHYSICIAN- DISPENSED EYELASH PRODUCTS
6.10 NAIL TREATMENT LASER DEVICES

7 MEDICAL AESTHETICS MARKET, BY PROCEDURE (USD MILLION; 2021—2028)
7.1 SURGICAL PROCEDURES
7.1.1 BREAST AUGMENTATION
7.1.2 RHINOPLASTY
7.1.3 FACELIFT AND BODY LIFT
7.1.4 OTHER SURGICAL PROCEDURES
7.2 NON-SURGICAL PROCEDURES
7.2.1 ANTI-AGING AND SKIN REJUVENATION
7.2.2 TATTOO AND SCAR REMOVAL
7.2.3 HAIR REMOVAL
7.2.4 LYPOLYSIS
7.2.5 OTHER NON-SURGICAL PROCEDURES

8 MEDICALS AESTHETICS MARKET, BY END-USER (USD MILLION; 2021—2028)
8.1 CLINICS, HOSPITALS, AND MEDICALS SPAS
8.2 BEAUTY CENTERS
8.3 HOME CARE SETTINGS

9 MEDICALS AESTHETICS MARKET, BY REGION (USD MILLION; 2021—2028)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 RECESSION IMPACT
9.2.2 US
9.2.3 CANADA
9.3 EUROPE
9.3.1 RECESSION IMPACT
9.3.2 GERMANY
9.3.3 UK
9.3.4 FRANCE
9.3.5 ITALY
9.3.6 SPAIN
9.3.7 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 RECESSION IMPACT
9.4.2 JAPAN
9.4.3 CHINA
9.4.4 INDIA
9.4.5 SOUTH KOREA
9.4.6 THAILAND
9.4.7 AUSTRALIA
9.4.8 INDONESIA
9.4.9 REST OF ASIA-PACIFIC
9.5 LATIN AMERICA
9.5.1 RECESSION IMPACT
9.5.2 BRAZIL
9.5.3 MEXICO
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 RECESSION IMPACT

10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN (2021-2023)
10.3 REVENUE ANALYSIS
10.4 MARKET SHARE ANALYSIS BY KEY PLAYERS 2022
10.4.1 GLOBAL ENERGY AND LIGHT-BASED AESTHETIC DEVICES MARKET
10.4.2 GLOBAL FACIAL AESTHETIC PRODUCTS MARKET
10.4.3 GLOBAL COSMETIC IMPLANTS MARKET
10.5 COMPANY EVALUATION MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT
10.6 START-UP/SME EVALUATION MATRIX
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING
10.7 C0OMPETITIVE SITUATION AND TRENDS (2021-2023)
10.7.1 NEW PRODUCT LAUNCHES & APPROVALS
10.7.2 DEALS
10.7.3 OTHER DEVELOPMENTS

11 COMPANY PROFILES**
(Business Overview, Products Offered, Industry-specific Developments for 2021-2023)***
11.1 KEY PLAYERS
11.1.1 ALLERGAN
11.1.2 ALMA LASERS
11.1.3 CYNOSURE
11.1.4 BAUSCH HEALTH COMPANIES
11.1.5 ANIKA THERAPEUTICS
11.1.6 CUTERA.
11.1.7 EL.EN. S.P.A.
11.1.8 INMODE
11.1.9 LUMENIS.
11.1.10 FOTONA
11.1.11 GALDERMA.
11.1.12 JOHNSON & JOHNSON
11.1.13 MERZ PHARMA
11.1.14 MEDYTOX
11.1.15 CANDELA CORPORATION
11.2 OTHER COMPANIES
11.2.1 SIENTRA
11.2.2 HUADONG MEDICINE.
11.2.3 VENUS CONCEPT
11.2.4 AEROASE CORP
11.2.5 SCITON
11.2.6 BOHUS BIOTECH AB
11.2.7 RECOSMO.
11.2.8 A.R.C. LASER
11.2.9 LUTRONIC.
11.2.10 SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., LTD.

12 APPENDIX